In recent years,SuddenlyThe new coronavirus epidemic has swept the world,atWhile bringing huge impact to the economies of various countries，Also brings new development opportunities to the biomedical industry。Shaanxi biopharmaceutical industry has formed a relatively complete category and system，has certain development potential and comparative advantages。How to seize opportunities，Achieve breakthrough development，Shaanxi Pharmaceutical Holding Group Co., Ltd. (hereinafter referred to as"Shaanxi Pharmaceutical Group") made a solid start and opened up a new situation.
August 2021，In the Provincial Party Committee、Provincial Government，Decision and deployment of the Provincial State-owned Assets Supervision and Administration Commission to speed up the construction of Qin Chuangyuan，Shaanxi Pharmaceutical GroupConcentrate your strengthBuilt Qin Chuangyuan Shaanxi International Biomedical Innovation Center,Anchoring target opportunities,Complete the outstanding shortcomings of the biopharmaceutical industry chain and innovation chain，Promote Shaanxi ProvinceBioThe pharmaceutical industry is rapidly moving towards the goal of 100 billion.
stake online sports betting
Leverage Qin Chuangyuan，Shaanxi biopharmaceutical industry moves towards the goal of 100 billion level
In Qin Chuangyuan Shaanxi International Biomedical Innovation Center,Shaanxi Pharmaceutical GroupWith Northwestern University,ShaanxiJointly established by Polytechnic University and othersInnovative drugsResearch Center,Future industrial innovation in Qinba medicinal and food resources and health product research and developmentInstitute，Actively work around the project. Several school-enterprise cooperation projectsalsoIn progress，Treatment of diabetic cardiomyopathyandTreatment of ischemic cardiovascular and cerebrovascular diseases's twoResearch on a Class I New DrugActively advancing;For screening human influenza、Rapid detection kit development project for susceptible populations of avian influenza，The information is being improved based on the conclusions of the expert demonstration meeting，Clinical trial research will be carried out as soon as possible; a series of anti-aging health products will be developed using authentic Shaanxi medicinal materials as raw materials，Strive to go on sale before the end of this year……
Qin Chuangyuan Shaanxi International Biomedicine Innovation Center is Shaanxi Pharmaceutical Group’s leveraging Qin ChuangyuanInnovation drivenPlatformConstructionOpportunity，Focus on strengthening the transformation of scientific and technological achievements and the incubation of innovative enterprises、Promote the high-quality transformation and development of the biopharmaceutical industry in Shaanxi Province，PlanInvestmentAn innovation center and achievement transformation center built with 100 million yuan.
Shaanxi Pharmaceutical Group Qin Chuangyuan Shaanxi International Biomedicine Innovation Center
This innovation center focuses on biopharmaceuticals,toChemical drugs、Modern Chinese Medicine、Medical Devices、Featuring comprehensive health services，After completion and operation, it will become the general platform and general window for the scientific and technological innovation-driven development of Shaanxi Pharmaceutical Group。
Since the construction of Qin Chuangyuan Shaanxi International Biomedical Innovation Center，Already launched4 school-enterprise cooperation projects, 3 independent innovations andTCM productsSecondary development project, jointly constructed with universities3 R&D platforms。Also driven by innovation、Transformation of results，Won 8 awards of various types、Obtained 8 new product approvals、15 patents、35 trademarks、28 copyrights，1 enterprise passed the certification of Shaanxi Enterprise Technology Center。
In terms of future layout，Deputy Secretary of the Party Committee of Shaanxi Pharmaceutical Group、General Manager Li Yuanrepresentation, the group has more considerations.
The group will follow"Basing、Platformization、Chainization、Internationalization、Capitalization” development ideas and the “career + industry + free trade zone” model，UniteddomesticBiomedicine advantageous enterprises and universities，Adopt pipeline cooperation、Equity Cooperation、Project cooperation and other ways，Strive to build a biomedical service outsourcing base、Biopharmaceutical professional incubation base and other industrial bases。
By playing“Biomedical service outsourcing base + biomedical professional incubation base” synergy effect，Finally formed by biotechnology、Modern Chinese Medicine、High quality generic drugs、Introduction and transformation of medical devices、High-quality health project、The radiating west, which focuses on six major fields including service outsourcing、Affects the whole country、Connecting with global innovative industrial clusters。
Biomedical service outsourcing baseSchematic diagram
“Leverage Qin Chuang’s original new drive platform，We will continue to focus on the two major tracks of biomedicine and traditional Chinese medicine modernization，By gathering high-end talents、Focus on key projects、Gathered industrial clusters，Create a new highland for the biomedical industry。”Introduced by Li Yuan, Groupwill investhundredYi layout"Qin Chuangyuan"，In 5-10 years, Qin Chuangyuan Shaanxi International Biomedical Innovation Center will be built into the most influential industrial landmark in the west - "Western Medicine Valley"，Comprehensive competitiveness ranks among the top ten biomedical industrial parks in my country。Estimated to be by the end of the “14th Five-Year Plan”，The output value of Shaanxi’s biopharmaceutical industry will reach 100 billion yuan。
Leverage Qin Chuangyuan to help“Qin Yao” goes abroad to the world
TCM is the treasure of Chinese culture，is my country’s unique health resource、Economic resources with huge potential、Technological resources with original advantages。Taking advantage of Qin Chuangyuan，Shaanxi Pharmaceutical Group has achieved leapfrog development in the construction of a modern traditional Chinese medicine industry system，Strengthen the chain by extending the chain through mending the chain，Formed the cultivation of Chinese medicinal materials、Trade flow、Research and development of traditional Chinese medicine、Pharmaceutical manufacturing、The entire industry chain of traditional Chinese medicine for pharmaceutical sales。
Shaanxi MedicineThe group’s deployment can be summarized with five keywords，Grab the source respectively、Promote circulation、Strong R&D、Big production、Expand the market。
Grassing the source is to accelerate the modernization and standardization of Chinese herbal medicine cultivation。GroupJoined with the Northwest National Engineering Laboratory for the Development of Endangered Medicinal Materials Resources to establish a traditional Chinese medicinal material seedling breeding platform，to“Leading enterprises + professional companies + scientific research institutions + farmers” operating model，Construction of Luonan, Suide, etc.15 Shaanxi authentic medicinal material planting bases and primary processing bases.
To promote circulation, we must vigorously promote the construction of a large circulation market for Chinese medicinal materials，System layout of Shaanxi’s three major modern warehousing and logistics bases for Chinese medicinal materials，Providing modern logistics services。This yearFebruary，The group has established a centralized medicinal material packaging、Warehouse、Trade、Traceback、Detection、A national-level traditional Chinese medicine distribution center integrating e-commerce and other functions--Gaoling Traditional Chinese Medicine City will be built into a city in the future"Northwestern Medicine Capital"，Transform Shaanxi Province’s traditional Chinese medicine resource advantages into economic advantages、Industrial advantages。
Gaoling Traditional Chinese Medicine City is open
Strong R&D relies on Qin Chuang’s original new platform，Integrate and optimize innovative resources，Strengthen cooperation with well-known domestic universities and research institutes，Focus on innovative traditional Chinese medicines、Secondary development of high-quality varieties、Classic famous prescription preparations and comprehensive health products, etc.，Accelerate the transformation of innovative achievements。
Large-scale production must follow the development trend of professional integration，Promote the entry of production and R&D factor enterprises such as Shanhaidan PharmaceuticalsSun Simiao High-tech PharmaceuticalsIndustrial base，Maximize release of production capacity，Promote the scale of traditional Chinese medicine industry、Clustering。
Sun Simiao High-tech PharmaceuticalsIndustrial baseProduction workshop
To expand the marketIntegrated sales force，Build an online + offline omni-channel sales network，Realize product promotion and My stake betting appterminal stake online sports bettingcoverage with the help of commercial platform，Further expand the market space、Increase product market share。
In addition,Shaanxi MedicineThe group will also respond to the national call，Strengthening international trade cooperation of traditional Chinese medicine，Focusing on cross-border trade of traditional Chinese medicine，Taking Iran’s saffron international trade cooperation as an opportunity，Accelerate with Southeast Asia、Europe、Africa etc.“One Belt, One Road”Cooperation with countries along the route，Promote the dual circulation of international and domestic trade in Chinese medicinal materials and health products; promote saffron、Longan、American ginseng、Deer Antler、Frankincense、Myrrh、Import of high-quality Chinese herbal medicine resources such as blood root，Cooperate to establish an overseas base for Chinese medicinal materials; establish an international marketing system，Develop international distributors，With XiaobenBirdWaiting for overseas e-commerce and logistics platforms to carry out cross-border e-commerce cooperation，Relying on domestic88 authentic Chinese herbal medicine logistics experimental bases and preliminary processing bases，Excellent expansion quality、Traceable authentic Chinese medicinal materials、Chinese medicine pieces、Sales of medicinal and edible productsWait,Push“Qin Yao”Go abroad and help traditional Chinese medicine go global.
Leverage the wisdom of Qin Chuangyuan to achieve high-quality development of the pharmaceutical and health industry
Strengthen the transformation and application of scientific and technological achievements，Transformation of results is fundamental，Practical application is the key。Since the construction of Qin Chuangyuan Shaanxi International Biomedical Innovation Center，Shaanxi Pharmaceutical Group“Borrowing Wisdom” Qin Chuangyuan，Advanced benchmarking、Accurate force，Carrying out international production capacity cooperation for COVID-19 vaccine research and development、Human vaccine production、There are many choices in the medical and health care industry"Optional Action"，Promote new development of the medical and health industry。
Via International"Vertical" expansion of cooperation，Shaanxi Pharmaceutical Group initiated the establishment of Eurasia International (Shaanxi) Health Industry Group Co., Ltd. (hereinafter referred to as "Eurasia International Health") with a registered capital of 1 billion yuan in Airport New City。Eurasia International Health’s first project is “New Crown Vaccine International Production Capacity Cooperation”，Currently，Has reached a preliminary cooperation intention with the Nigerian government，And signed a framework cooperation agreement with Sinopharm China Biotechnology Co., Ltd.，Exports to Nigeria this year are expected to exceed50 million doses of COVID-19 vaccine and related ancillary products.
While doing a good job in international market cooperation，Shaanxi Pharmaceutical Group also focuses on strengthening cooperation with domestic leading enterprises“Horizontal” cooperation. The group has set up a professional team to go to the countryMultipleLeading biopharmaceutical companies conduct business inspections and docking，Currently, stake sports betting My stake betting appappproject negotiations have begunMore than 30 times，In clinical trial hospital、GLP laboratory construction、Reached cooperation intention in special medical food development and other aspects。
To fill the gap in human vaccine production enterprises in Shaanxi，Vigorously improve Shaanxi’s biomedical research and development、Production level，The group plans to introduce people with rich R&D experience and strong strengthofThe R&D team jointly funded the construction of a vaccine R&D center and production base。Achieved in the shortest time1-2 regions urgently need human vaccine varieties to be put into production，Complete clinical approval documents for 1-2 biological products with great market potential，Carry out preclinical studies on 2-3 industry-leading biological products，Realizing Shaanxi’s vaccine R&D and production field from scratch、Breakthrough from zero to one。
In the medical and health care industry，Shaanxi Pharmaceutical Group is positioned as the leader in medical and health services in the province，Meet the aging society、Multi-level needs of the silver economy，Promoting healthy elderly care services for the purpose，Actively extend and expand business scope，Jointly expand terminal market，Speed upPromote health care, medical complexes, retirement apartments, etc.Project。
Pengcheng Wanli wind is strong，Set sail and set off again。This year，It is the year of the 20th National Congress of the Communist Party of China，StandingAt the historical intersection of the “Two Centenary Goals”，Shaanxi Pharmaceutical Group is based on resource endowment and industrial foundation，Actively assume the responsibility of the main unit of the biopharmaceutical industry chain in Shaanxi Province，Leverage、Taking advantage of the situation、Borrowing Qinchuang’s original new drive platform，On the new journey of high-quality development of the biomedical industry chain，Work hard all the way、Song and advance。
